Efficacy of Bevacizumab Combined with Albumin-Bound Paclitaxel in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer.
CONCLUSIONS: In comparison with ABP alone, BEV combined with ABP applied in the treatment of platinum-resistant recurrent ovarian cancer prominently improves the clinical efficacy, PFS and OS, with good tolerance of patients, which is worthy of popularization and application in clinical practice.
PMID: 31983098 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Abraxane | Alopecia | Avastin | Brain | Cancer | Cancer & Oncology | Carbohydrates | Gastroenterology | Neurology | Ovarian Cancer | Ovaries | Statistics